KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Common Equity: 2009-2024

Historic Common Equity for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $1.1 billion.

  • Chemed's Common Equity fell 1287.25% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1287.25%. This contributed to the annual value of $1.1 billion for FY2024, which is 100.35% up from last year.
  • According to the latest figures from FY2024, Chemed's Common Equity is $1.1 billion, which was up 100.35% from $1.1 billion recorded in FY2023.
  • Over the past 5 years, Chemed's Common Equity peaked at $1.1 billion during FY2024, and registered a low of $623.3 million during FY2021.
  • Its 5-year average for Common Equity is $910.0 million, with a median of $901.2 million in 2020.
  • In the last 5 years, Chemed's Common Equity plummeted by 3083.97% in 2021 and then skyrocketed by 3870.73% in 2023.
  • Over the past 5 years, Chemed's Common Equity (Annual) stood at $901.2 million in 2020, then crashed by 30.84% to $623.3 million in 2021, then rose by 28.15% to $798.7 million in 2022, then soared by 38.71% to $1.1 billion in 2023, then grew by 1.0% to $1.1 billion in 2024.
  • Its last three reported values are $1.1 billion in FY2024, $1.1 billion for FY2023, and $798.7 million during FY2022.